PTC
TARO

Private Trust Company’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Private Trust Company’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-77
Closed -$2.92K – 2398
2023
Q2 		$2.92K Hold
77
– – ﹤0.01% 2037
2023
Q1 		$1.87K Sell
77
-17
-18% -$496 ﹤0.01% 2093
2022
Q4 		$3K Hold
94
– – ﹤0.01% 1979
2022
Q3 		$3K Sell
94
-4
-4% -$138 ﹤0.01% 1842
2022
Q2 		$4K Buy
+98
New +$3.74K ﹤0.01% 1844

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Private Trust Company's TARO Position: Q3 2023 in Review

Private Trust Company sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2023, closing a stake of 77 shares — an estimated $2.92K sold.

Private Trust Company first reported a position in TARO in Q2 2022 and held it in 5 quarters. The position peaked at $4K in Q2 2022. 82 funds tracked by Wall St. Rank hold TARO as of Q3 2023.

  • Private Trust Company reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2023 after selling out during the quarter.
  • Private Trust Company sold 77 Taro Pharmaceutical Industries Ltd. shares in Q3 2023, an estimated $2.92K.
  • Private Trust Company first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2022 and held it in 5 quarters.
  • Private Trust Company's Taro Pharmaceutical Industries Ltd. position peaked at $4K in Q2 2022.
  • 82 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2023.

Based on Private Trust Company's 13F filing for Q3 2023, filed 18 Oct 2023.